Cerus (CERS) vs OrthoPediatrics (KIDS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Cerus (CERS) has outperformed OrthoPediatrics (KIDS) over the past year, gaining 37.7% versus a gain of 20.6%. Over five years, CERS leads with a -62.4% price change compared with -65.6% for KIDS. OrthoPediatrics is the larger company by market cap ($565.3 million vs $463.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | KIDS |
|---|---|---|
| Share price | $2.30 | $21.65 |
| Market cap | $463.51M | $565.28M |
| 1-day change | +0.88% | -0.51% |
| YTD return | +11.65% | +21.90% |
| 1-year return | +37.72% | +20.61% |
| 5-year return | -62.42% | -65.60% |
| EPS (TTM) | $-0.03 | $-1.68 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $26.74 |
| 52-week low | $1.38 | $14.42 |
| Distance from 52-week high | -33.72% | -19.04% |
| Analyst consensus | none | none |
| Avg. price target upside | +123.04% | +25.73% |
| Average volume | 2.13M | 210.60K |
| Shares outstanding | 201.52M | 26.11M |
| Employees | 261 | 602 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERS has outperformed KIDS by 17.1 percentage points over the past year.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Health Care · Medical/Dental Instruments · 261 employees
About OrthoPediatrics
KIDS stock →OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products.
Health Care · Medical/Dental Instruments · 602 employees
CERS vs KIDS FAQ
Which is bigger, Cerus or OrthoPediatrics?
OrthoPediatrics (KIDS) is larger, with a market capitalization of $565.28M compared with $463.51M for Cerus (CERS).
Which stock has performed better over the past year, CERS or KIDS?
CERS returned +37.72% over the past 12 months, compared with +20.61% for KIDS (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and OrthoPediatrics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.